Ricky Goldwasser Analyst PerformanceAnalyst at Morgan StanleyRicky Goldwasser is a stock analyst at Morgan Stanley focused in the healthcare sector, covering 17 publicly traded companies. Over the past year, Ricky Goldwasser has issued 14 stock ratings, including buy and hold recommendations. While full access to Ricky Goldwasser's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ricky Goldwasser's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings100 Last 12 YearsBuy Recommendations62.24% 61 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution98RatingsDistribution of strong buy, buy, hold, and sell ratings by Ricky Goldwasser.RatingPercentageCount Strong Buy0.0%0 ratings Buy62.2%61 ratings Hold32.7%31 ratings Sell5.1%5 ratingsOut of 98 total stock ratings issued by Ricky Goldwasser at Morgan Stanley, the majority (62.2%) have been Buy recommendations, followed by 32.7% Hold and 5.1% Sell.Best & Worst CallsBest Call000.0%CAHJul 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHGAug 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE82.4% of companies on NYSE14 companiesNASDAQ11.8% of companies on NASDAQ2 companiesOTCMKTS5.9% of companies on OTCMKTS1 companyRicky Goldwasser, an analyst at Morgan Stanley, currently covers 17 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare15 companies88.2%Consumer Discretionary1 company5.9%Miscellaneous1 company5.9%Ricky Goldwasser of Morgan Stanley specializes in stock coverage within the Healthcare sector, with additional focus on Consumer Discretionary and companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES11 companies64.7%LIFE SCIENCES TOOLS & SERVICES2 companies11.8%HEALTHCARE TECHNOLOGY1 company5.9%HOSPITAL & MEDICAL SERVICE PLANS1 company5.9%RETAIL - DRUG STR1 company5.9%Miscellaneous1 company5.9% Ricky Goldwasser's Ratings History at Morgan Stanley Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCRLCharles River Laboratories International8/7/2026Boost Price Target$264.97$300.00Overweight$0.0000.00% ROILHLabcorp7/31/2026Boost Price Target$308.99$338.00Overweight$0.0000.00% ROICRLCharles River Laboratories International7/9/2026Boost Price Target$224.07$260.00Overweight$0.0000.00% ROICRLCharles River Laboratories International6/17/2026Upgrade$184.89$220.00Overweight$0.0000.00% ROICNCCentene6/4/2026Boost Price Target$62.10$57.00Equal Weight$0.0000.00% ROIDOCSDoximity5/14/2026Lower Price Target$23.52$35.00Overweight$0.0000.00% ROICNCCentene3/4/2026Boost Price Target$45.01$45.00Equal Weight$0.0000.00% ROIDOCSDoximity2/6/2026Lower Price Target$33.30$49.00Overweight$0.0000.00% ROIUNHUnitedHealth Group1/23/2026Lower Price Target$354.80$409.00Overweight$0.0000.00% ROIDOCSDoximity12/15/2025Upgrade$43.77$65.00Overweight$0.0000.00% ROICRLCharles River Laboratories International11/11/2025Boost Price Target$170.86$185.00Equal Weight$0.0000.00% ROICNCCentene10/14/2025Boost Price Target$36.19$38.00Equal Weight$0.0000.00% ROIUNHUnitedHealth Group9/12/2025Boost Price Target$357.66$395.00Overweight$0.0000.00% ROIUNHUnitedHealth Group8/20/2025Lower Price Target$299.20$325.00Overweight$0.0000.00% ROICNCCentene8/4/2025Lower Price Target$26.76$28.00Equal Weight$00.0000.00% ROILHLabcorp7/25/2025Boost Price Target$267.42$306.00Overweight$000.0000.00% ROICNCCentene7/10/2025Downgrade$33.00$33.00Equal Weight$00.0000.00% ROILHLabcorp6/11/2025Boost Price Target$260.48$283.00Overweight$000.0000.00% ROICNCCentene6/9/2025Initiated Coverage$55.56$70.00Overweight$00.0000.00% ROIUNHUnitedHealth Group5/14/2025Lower Price Target$319.37$374.00Overweight$000.0000.00% ROIDOCSDoximity4/24/2025Lower Price Target$55.94$60.00Equal Weight$00.0000.00% ROIUNHUnitedHealth Group4/22/2025Lower Price Target$423.75$563.00Overweight$000.0000.00% ROICRLCharles River Laboratories International2/5/2025Lower Price Target$162.95$184.00Equal Weight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
